
- •Ticket 1
- •3. Antihypertensive agents affecting water-salt exchange. Classification. Mechanism of action. Side effects. Contraindications. Comparative evaluation of preparations.
- •4. Antiseptics of aromatic and aliphatic series. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Ticket 2.
- •Distribution of drugs in the body. Biotransformation of drugs in the body and ways of their extraction. The concept of bioavailability.
- •2. Binding, engraving, adsorbating, irritating substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •3. Drugs stimulating fibrinolysis. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative assessment.
- •4. Halogen-containing antiseptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Ticket 3.
- •1. Suction of medicinal substances from the place of administration. Transportation of medicinal substances through cellular membranes.
- •2.Tranquilizers. Classification. Action mechanism. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •1) Means used for diagnostic purposes
- •Indications: used in case of weakened but preserved gastric function
- •2. Antiseptics - compounds of metals. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Season 4
- •Gink derivatives
- •Indications for use:
- •I Inhibition of the activity of the thromboxane system
- •III Drugs that inhibit the binding of fibrinogen to platelet glycoprotein receptors
- •Season 5
- •Indications:
- •Season 6
- •Indications:
- •3) Preparations for topical use:
- •4) Combined preparations of sulfonamides with trimethoprim
- •Ticket 7
- •1. Development of pharmacology in Russia. Pharmokopeia, its legal significance. Prescription - Jur. Document.
- •2. Counterarkinsonian funds. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Rational combination and combined drugs for the treatment of hypertension. Explain the rationality of the application.
- •Ticket 8
- •3. Anticoagulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 9
- •3. Drugs used to treat bronchial asthma. Classification. Mechanisms of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 10
- •1. Definition of pharmacology as a science, its tasks, place among other medical and biological sciences. Scientific substantiation of the need for animal experiments.
- •Ticket 11
- •1. Dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Antipsychotics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs. The concept of neuroleptanalgesia
- •3. Cardiac glycosides. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antifungal drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •I. Means used in the treatment of diseases caused by pathogenic fungi:
- •II. Drugs used in the treatment of diseases caused by opportunistic fungi (for example, with candidiasis):
- •Ticket number 12
- •Types of action of medicinal substances
- •2. Alpha and alpha, beta adrenomimetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 13
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov)
- •3. Preparations of sex hormones and their antagonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •Indications for use:
- •4. Antimalarial drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket 14
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Local anesthetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for the use of local anesthetics:
- •3. Preparations of fat-soluble vitamins. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Vitamin a preparations are indicated:
- •Ticket 15
- •2. Nootropics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •3. Antihypertensive drugs of peripheral neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-tuberculosis drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 16
- •1. Types of action of medicinal substances.
- •2. Sympatholytic remedies. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiviral agents. Classification. Mechanism of action. The nature of the action. Spectrum of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 17.
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •2. Analeptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Choleretic drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-spirochete drugs. Classification. Mechanism of action. Indications for use. Side effects. Comparative characteristics.
- •Ticket 18.
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov)
- •2. Beta-adrenergic agonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Antacids. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative characteristics.
- •Ticket 19
- •1. The combined effect of drugs. Synergy. Antagonism. Antidote.
- •2.Sleeping drugs. Classification by chemical structure. Mechanism of action. Side effects. Contraindications Comparative evaluation. Possibilities for the development of addiction.
- •3. Class II antiarrhythmic drugs (Beta-blockers). Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Complications arising from the use of antibiotics, measures for their prevention.
- •Ticket 20
- •1. Changes in the body's reactions to medicinal substances during their repeated administration. The concept of addiction, drug dependence, tachyphylaxis, sensitization. Cumulation of drugs.
- •2. Ganglion blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of the drug.
- •3. Means that reduce the secretion of gastric glands. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •Ticket 21
- •1. Basic principles of first aid for acute drug poisoning.
- •2. Alpha-adrenergic blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •3.Calcium channel blockers for the treatment of coronary heart disease. Classification Mechanism of action Side effects Contraindications Comparative assessment of drugs
- •Ticket number 22
- •3). Leukopoiesis stimulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket number 23
- •2). Narcotic (opioid) analgesics. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs. Antagonists of narcotic analgesics.
- •1. Plant origin
- •2. Synthetic morphine substitutes
- •3). Gastroprotectors. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket number 24
- •2). Antiepileptic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •III. Agents that activate the gabAergic system
- •IV. Agents that lower the activity of the glutamatergic system
- •3). Diuretics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •Ticket 25
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •3. Antitussives. Classification Mechanism of action Indications for use Side effects Contraindications Comparative assessment of drugs
- •Ticket 26
- •2. Sedatives. Classification. Mechanism of action. Indications for use Side effects Contraindications Comparative evaluation of drugs.
- •3. Anti-inflammatory drugs of steroid structure. Classification Mechanism of action Indications for use Side effects Contraindications Comparative assessment of drugs
- •Ticket 27
- •1. Basic principles and methods of testing new medicinal substances. The concepts of "placebo" and "blind" control. The ethical side of prescribing a placebo.
- •3. Means that help stop bleeding (hemostatics). Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •3) Preparations for topical use:
- •4) Combined preparations of sulfonamides with trimethoprim
- •Ticket number 28
- •1. Combined action of medicinal substances. Synergy. Antagonism. Antidote.
- •2. Psychostimulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket number 29
- •1. Dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Alpha-adrenergic blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Drugs affecting immunity. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antifungal drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 30
- •2. Sympatholytic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Preparations of pancreatic hormones. Synthetic hypoglycemic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-spirochete drugs. Classification. Mechanism of action. Indications for use. Side effects. Comparative characteristics.
- •Ticket 31
- •1. Distribution of medicinal substances in the body. Biotransformation of medicinal substances in the body and ways of their excretion. Concept and bioavailability.
- •2. Narcotic (opioid) analgesics. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs. Antagonists of narcotic analgesics.
- •3. Laxatives. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Complications arising from the use of antibiotics, measures for their prevention.
- •Ticket 32.
- •3. Stimulants of respiration. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 33.
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Antipsychotics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs. The concept of neuroleptanalgesia.
- •3. Class IV antiarrhythmics (calcium channel blockers). Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 34
- •1) Development of pharmacology in Russia. Pharmacology and its legal significance. Treating the recipe as a legal document.
- •3... Antihypertensive drugs that affect the renin-angiotensin system. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiviral agents. Classification. Mechanism of action. The nature of the action. Indications for use. Side effects. Contraindications Comparative characteristics of drugs.
- •Ticket 35
- •6. Homeopathy, basic principles. Evaluation of the homeopathic treatment method.
- •2. Nootropics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •3) Drugs used in myocardial infarction. Classification. Mechanism of action. Side effects. Contraindications Indications for use. Comparative characteristics
- •Ticket 36
- •2. Local anesthetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for the use of local anesthetics:
- •3) Anti-atherosclerotic drugs. Classification, Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation.
- •Indications:
- •Ticket 37
- •Basic principles (mechanisms) of action of medicinal substances. Their interaction with receptors.
- •Antihypertensive drugs of central neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •1. Basic principles (mechanisms) of action of medicinal substances. Their interaction with receptors.
- •3. Antihypertensive drugs of central neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 38
- •4. Antiblastic substances. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 39
- •4. Differences between chemotherapeutic agents and antiseptics. Basic principles of ht. Criteria for evaluation.
- •Ticket 40.
- •3. Preparations of water-soluble vitamins. Classification. Mechanism of action. Indications. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antihelminthic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 41.
- •1. Principles of drug discovery. Ways of synthesis of pharmacological substances. Obtaining preparations from plant and animal raw materials.
- •Inhalation : volatile liquids: ether, fluorothane, sevoflurane, isoflurane, methoxyflurane
- •3. Class III antiarrhythmic drugs (potassium channel blockers). Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •4. Dyes. Detergents. Oxidizing agents. Acids and alkalis.
- •Ticket 42
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov).
- •2. Beta-adrenergic agonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Vomiting and antiemetic. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 43
- •1. The combined action of medicinal substances. Synergy. Antagonism. Antidote.
- •2. Antiparkinsonian drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Enzyme preparations. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket 44.
- •The dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Curariform funds. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Means that affect appetite. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •1.Media that stimulate appetite:
- •Ticket 45.
- •1. Types of action of medicinal substances.
- •2. Antidepressants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Gink derivatives
- •Indications for use:
- •4. Anti-tuberculosis drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 46
- •Ticket 47
- •3. Means that increase the tone and contraction of the myometrium. Classification. Mechanism of action. Indications for use. Contraindications Comparative evaluation of drugs.
- •4. Halogen-containing antiseptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Season 48
- •Distribution of drugs in the body. Biotransformation of drugs in the body and ways of their extraction. The concept of bioavailability.
- •2). Antiepileptic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •III. Agents that activate the gabAergic system
- •IV. Agents that lower the activity of the glutamatergic system
- •3. Antiadrenergic drugs for the treatment of coronary heart disease. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiseptics - metal compounds. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Inhalation : volatile liquids: ether, fluorothane, sevoflurane, isoflurane, methoxyflurane
- •3. Blockers of calcium channels for the treatment of hypertension. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 50
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •2. Ganglion blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of the drug.
- •3. Preparations of pituitary hormones. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use
- •Indications for use
- •Indications for use:
- •Ticket 51
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Alpha and alpha, beta adrenomimetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Glycosidic intoxication. Preventive and emergency measures.
- •Ticket 52
- •3. Antihypertensive drugs of myotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
Ticket 26
1. Types of drug therapy. The dependence of the action of pharmacological agents on the initial state of the organism (the influence of age, sex, genetic factors, circadian rhythms and pathological background).
• Etiotropic (causal) therapy - elimination of the cause of the disease: the use of antimicrobial, antiviral and antiparasitic agents for infectious diseases, antidotes for poisoning. • Pathogenetic therapy - the effect on the pathogenetic mechanisms of diseases: the appointment of antihypertensive drugs for arterial hypertension, cardiac glycosides for heart failure, anti-inflammatory drugs for rheumatic diseases, psychotropic drugs for the treatment of mental disorders. • Symptomatic therapy - elimination or reduction of individual manifestations of the disease: the use of painkillers and antipyretic drugs. • Substitution therapy - replenishment of an insufficient amount of natural metabolites of the body: the use of vitamin, hormonal, enzyme agents, salts of iodine, fluorine, iron, calcium. For preventive purposes, antiseptics, disinfectants, antiviral, vitamin agents are prescribed. • Gender - Clinical studies indicate certain gender differences in drug metabolism and sensitivity to certain pharmacological effects. So, due to the fact that male sex hormones stimulate the synthesis of microsomal liver enzymes, the elimination of certain medicinal substances (paracetamol, verapamil, benzodiazepines, propranolol) occurs faster in men. The existing sex differences in ethanol metabolism are associated with the high activity of alcohol dehydrogenase in men. The arrhythmogenic effect of antiarrhythmic drugs (ventricular arrhythmias of the "pirouette" type) more often occurs in women, the analgesic effect of morphine occurs in women in lower doses than in men. Funds,
•Age. Age-related changes in drug action are especially evident in newborns and patients over 60 years of age.
Newborns are more sensitive to drugs. This is mainly due to the imperfection of the metabolism of medicinal substances (due to the lack of enzymes), reduced renal function, increased permeability of the blood-brain barrier, underdevelopment of the endocrine, nervous and other systems of the body.
In old and senile age, pharamacokinetic processes are slow. The change in the rate of absorption is mainly associated with a decrease in the acidity of gastric juice, a decrease in blood flow in the intestine, inhibition of active absorption systems, etc. A decrease in the metabolism of medicinal substances with age is associated with a decrease in the activity of liver enzymes and a decrease in hepatic blood flow. Decreased renal function leads to a slower elimination of drugs. • Genetic factors. There are significant differences in the individual sensitivity of people to drugs, determined by genetic factors. The section of pharmacology Pharmacogenetics studies the role of genetic factors in changing the action of drugs. Very often, individual differences in the action of drugs are due to differences in their metabolism. This happens due to a change in the activity of enzymes that metabolize drugs, which is often associated with a mutation of genes that control the synthesis of these enzymes. Violation of the structure and function of the enzyme is called enzymopathy (fermentopathy). With enzymopathies, the activity of the enzyme can be increased (the metabolism of drugs is accelerated and their action is weakened) or decreased (the metabolism slows down, which can lead to an increase in the action of the drug and the appearance of toxic effects). With a genetic deficiency of some enzymes, atypical reactions to substances (idiosyncrasy) may occur. With enzymopathies, the activity of the enzyme can be increased (the metabolism of drugs is accelerated and their action is weakened) or decreased (the metabolism slows down, which can lead to an increase in the action of the drug and the appearance of toxic effects). With a genetic deficiency of some enzymes, atypical reactions to substances (idiosyncrasy) may occur. With enzymopathies, the activity of the enzyme can be increased (the metabolism of drugs is accelerated and their action is weakened) or decreased (the metabolism slows down, which can lead to an increase in the action of the drug and the appearance of toxic effects). With a genetic deficiency of some enzymes, atypical reactions to substances (idiosyncrasy) may occur.
• Pathological background - various pathological conditions can cause changes in the pharmacokinetics and pharmacodynamics of drugs in diseases of the gastrointestinal tract, there may be a decrease in the rate and degree of absorption of drugs. Some diseases of the lungs and cardiovascular system lead to significant changes in hemodynamics, which affects the distribution of medicinal substances. In case of impaired renal function, the effect of substances excreted by the kidneys in an unchanged form is lengthened. In the focus of inflammation, the effect of local anesthetics is sharply weakened.